ConductScience.org, home

Paper3907188

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

Prince GA and 3 others. Virus Res, 1985. Cited by 196 papers, by iCite.

Cite this record

ConductScience Library. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Papers, record 3907188. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3907188

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.
PubMed
Journal
Virus Res
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
196
iCite
Relative citation ratio, by iCite
5.62
iCite
Revised in PubMed
2021-12-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Prince GAG A
2Hemming VGV G
3Horswood RLR L
4Chanock RMR M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Respirovirus InfectionsMajor topic
Animals
Antibodies, Viral
Arvicolinae
Cell Line
Enzyme-Linked Immunosorbent Assay
Humans
Immune Sera
Immunization, Passive
Immunoglobulin G
Immunosuppression Therapy
Immunotherapy
Respiratory Syncytial Viruses

Source PubMed

Download CSV of topics

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 196 citations.

PMIDTitleJournalYearIn PapersSource
37902399Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.J Virol2023https://conductscience.org/library/papers/37902399PubMed
36839426Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV).Pathogens2023https://conductscience.org/library/papers/36839426PubMed
36655191Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial.Open Forum Infect Dis2023https://conductscience.org/library/papers/36655191PubMed
34423407Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections.Appl Microbiol Biotechnol2021https://conductscience.org/library/papers/34423407PubMed
32288233Le virus respiratoire syncytial: importance en pathologie, méthodes diagnostiques, traitement et prévention.Ann Inst Pasteur Actual1995https://conductscience.org/library/papers/32288233PubMed
31209804Lipopolysaccharide Inhibits FI-RSV Vaccine-enhanced Inflammation Through Regulating Th Responses.Curr Med Sci2019https://conductscience.org/library/papers/31209804PubMed
29315059Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.Viral Immunol2018https://conductscience.org/library/papers/29315059PubMed
29213258The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years.Front Microbiol2017https://conductscience.org/library/papers/29213258PubMed
29035131
RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
Expert Rev Clin Immunol2017https://conductscience.org/library/papers/29035131PubMed
28799905Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.Cell Host Microbe2017https://conductscience.org/library/papers/28799905PubMed
28149851Virus vs. virus: adenovirus vectored vaccine to defeat respiratory syncytial virus.Ann Transl Med2016https://conductscience.org/library/papers/28149851PubMed
27550346Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27550346PubMed
26772634Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.Vaccine2016https://conductscience.org/library/papers/26772634PubMed
26544795Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.Viral Immunol2016https://conductscience.org/library/papers/26544795PubMed
26541285Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.J Transl Med2015https://conductscience.org/library/papers/26541285PubMed
26367224Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus.Bone Marrow Transplant2016https://conductscience.org/library/papers/26367224PubMed
26335771Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy.Vaccine2015https://conductscience.org/library/papers/26335771PubMed
26100926WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.Vaccine2016https://conductscience.org/library/papers/26100926PubMed
25793508A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.PLoS One2015https://conductscience.org/library/papers/25793508PubMed
25713060Challenges and opportunities in developing respiratory syncytial virus therapeutics.J Infect Dis2015https://conductscience.org/library/papers/25713060PubMed

See all 80 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3907188

GET https://conductscience.org/api/papers/v1/3907188/cited_by?page=2